Fluorescence detection and diagnosis of non-Melanoma skin cancer at an early stage

Lasers in Surgery and Medicine

Volumn 41, Issue 2, 2009, Pages 96-103

  De Leeuw, Jaap ^a,b   Van der Beek, Nick ^a,c   Neugebauer, W Dieter ^a,d   Bjerring, Peter ^e   Neumann, H A Martino ^b  

^a ZBC MultiCare   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d EuromedClinic   (Germany)

^e SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

5 aminolevulinic acid; Actinic keratosis; Fluorescence detection; Liposomes; Skin cancer

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; LIPOSOME;

ACTINIC KERATOSIS; ADULT; ARTICLE; BACK; CAMERA; CANCER DIAGNOSIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIGITAL IMAGING; DRUG CLEARANCE; EARLY CANCER; ENCAPSULATION; FACE; FALSE NEGATIVE RESULT; FEMALE; FLUORESCENCE HISTOCHEMISTRY; FLUORESCENCE IMAGING; HAND; HUMAN; HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; NECK; PHOTOSENSITIVITY; PHOTOTOXICITY; PRECANCER; PRIORITY JOURNAL; SEBACEOUS GLAND; SKIN CANCER; SKIN TUMOR; THORAX; ULTRAVIOLET A RADIATION; VERRUCA VULGARIS; WORKER;

AMINOLEVULINIC ACID; EARLY DETECTION OF CANCER; FEMALE; FLUORESCENCE; HUMANS; LIPOSOMES; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS;

EID: 60849105383     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20739     Document Type: Article

References (52)

1. Marks R. An overview of skin cancers. Incidence and causation. Cancer 1995;75:607-612.
2. English DR, Armstrong BK, Kricker A, Fleming C. Sunlight and cancer. Cancer Causes Control 1997;8:271-283.
3. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000;42:S4-S7.
4. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002;146(Suppl 61):1-6.
5. Trakatelli M, Ulrich C, del Marmol V, Euvrard S, Stockfleth E, Abeni D. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: Accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol 2007;156(S3):1-7.
6. Marks R, Rennie G. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988:795-797.
7. Jorizzo JL, Carney PS, Ko WT, Robins P. Treatment options in the management of actinic keratosis. Cutis 2004;74(S6):9-17.
8. Epstein E. Quantifying actinic keratosis: Assessing the evidence. Am J Clin Dermatol 2004;5:141-144.
9. Ackerman AB, Mones JM. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol 2006;155:9-22.
10. Ceilly RI. Modalities and mechanisms of action. In: The field treatment of actinic keratosis. Skin Aging 2004;(Suppl):3-5.
11. Oppel T, Korting HC. Actinic keratosis: The key event in the evolution from photodaged skin to squamous cell carcinoma. Skin Pharmacol Physiol 2004;17:67-76.
12. Dodson JM, DeSpain J, Hewett JE, Clark DP. Malignant potential of actinic keratoses and the controversy over treatment: A patient-oriented perspective. Arch Dermatol 1991;127:1029-1031.
13. Rossi R, Mori M, Lotti T. Actinic keratosis. Int J Dermatol 2007;46:895-904.
14. Housman TS, Feldman SR, Williford PM, Fleisher AB. Skin cancer is among the most costly of all cancers to treat for Medicare population. J Am Acad Dermatol 2003;48:425-429.
15. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B: Biol 2001;63:8-18.
16. Young AR. Tanning devices-fast track to skin cancer? Pigment Cell Res 2004;17:2-9.
17. MacKie RM. Long-term health risk to the skin of ultraviolet radiation. Prog Biophys Mol Biol 2006;92:92-96.
18. The International Agency for Research on Cancer Working Group on Artificial Ultraviolet Light and Skin Cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systemic review. Int J Cancer 2006;120:1116-1122.
19. Nijsten TEC, Stern RS. The increased risk of skin cancer is persistent after discontinuation of psoralen+ ultraviolet A: A cohort study. J Invest Dermatol 2003;121:252-258.
20. Lim JL, Stern RS. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. J Invest Dermatol 2005;124:505-513.
21. Vitasa BC, Taylor HR, Strickland PT, Rosenthal F, West S. Association of non-melanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 1990;65:2811-2817.
22. Buja A, Lange JH, Perissinotto E, Rausa G, Grigoletto F, Canova C, Mastrangelo G. Cancer incidence among male military and civil pilots and flight attendants: An analysis on published data. Toxicol Ind Health 2005;21:273-282.
23. Moehrle M. Outdoor sports and skin cancer. Clin Dermatol 2008;26:12-15.
24. Schwartz RA, Bridges TM, Butani AK, Ehrlich A. Actinic keratosis: An occupational and environmental disorder. J Eur Acad Dermatol Venereol 2008:1-9.
25. Masini C, Fuchs PG, Gabrielli F, Starks S. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 2003;139:890-894.
26. Euvrard S, Kanitakis J, Claudy A. Medical progress: Skin cancers in organ transplant recipients. N Engl J Med 2003;348:1681-1691.
27. De Hertog SAE, Wensveen CAH, Bastiaens MT, Kielich CJ. Leiden skin cancer study. Relation between smoking and skin cancer. J Clin Oncol 2001;19:231-238.
28. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
29. Venna SS, Lee D, Stadecker MJ, Rogers GS. Clinical recognition of actinic keratoses in a high-risk population. Arch Dermatol 2005;141:507-509.
30. Smits T, Kleinpenning MM, Blokx WAM, Kerkhof PCM, van Erp PEJ, Gerritsen MP. 2007; Fluorescence diagnosis in keratinocytic intraepidermal neoplasias. J Am Acad Derma-tol 2007;57:824-831.
31. Trakatellis A, Gerochristos I, Trakatelli M. The programme of community action in the field of health (2007-2013). Pharm Policy Law 2008;2005, 2006, 8:3-11.
32. Ericson MB, Sandberg C, Gudmundson F, Rosen A, Larkö O. Fluorescence contrast and threshold limit: Implications for photodynamic diagnosis of basal cell carcinoma. J Photochem Photobiol B: Biol 2003;69:121-127.
33. Svaasand LO, Wyss P, Wyss MT, Tadir Y, Tromberg BJ, Berns MW. Dosimetry model for photodynamic therapy with topically administered photosensitizers. Lasers Surg Med 1996;18:139-149.
34. Moan J, Ma LW, Iani V. On the pharmacokinetics of topically applied 5-aminolevulinic acid and two of its esters. Int J Cancer 2001;92:139-143.
35. Ackermann G, Abels C, Baumler W, Langer S, Landthaler M, Lang EW, Szeimies RM. Simulations on the selectivity of 5-aminolevulinic acid-induced fluorescence in vivo. J Photochem Photobiol B: Biol 1998;47:121-128.
36. Hua Z, Gibson SL, Forster TH, Hilf R. Effectiveness of delta- aminolevulinic acid-induced protoporphyrin as a photosensi- tizer for photodynamic therapy in vivo. Cancer Res 1995;55:1723-1731.
37. Christiansen K, Bjerring P, Troilius A. 2007; 5-ALA photo-dynamic photorejuvenation-optimization of treatment regume based on normal-skin fluorescence measurements.Lasers Surg Med 2007;39:302-310.
38. Hope MJ, Kitson CN. Liposomes: A perspective for dermatologists. Dermatol Clin 1993;11:143-154.
39. Lieb L, Ramchandran C, Egbaria K, Weiner N. Topical delivery enhancement with multilamellar liposomes into pilosebaceous units. J Invest Dermat 1992;99:108-113.
40. Artmann C, Roding J, Ghyczy M, Prazel HG. Liposomes from soya phospholipids as percutaneous drug carriers. Arzeim Forsch 1990;40:1365-1368.
41. Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transepidermal osmotic gradients and hydration force. Biochim Biophys Acta 1992;1104:226-232.
42. Plessis J, Egbaria K, Weiner N. Influence of formulation factors on the deposition of liposomal components into the different strata of the skin. J Soc Cosmet Chem 1992;43:93-100.
43. Ostro M. Liposomes. Sci Am 1987;256:102-111.
44. Verma DD, Verma S, Blume G, Fahr A. Liposomes increase skin penetration of entrapped and nonentrapped hydrophilic substances into human skin: A skin penetration and confocal laser scanning microscopy study. Eur J Pharm Biopharm 2003;55:271-277.
45. Bäumler W, Abels C, Szeimies RM. Fluorescence diagnosis and photodynamic therapy in dermatology. Med Laser Appl 2003;18:47-56.
46. Fauteck J, Ackermann G, Birkel M, Breuer M, Moor ACE, Ebeling A, Ortland C. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses. Arch of Dermatol Res 2008;300:53-60.
47. Gambichler T, Moussa G, Altmeyer P. A pilot study of fluorescence diagnosis of basal cell carcinoma using a digital flash light-based imaging system. Photodermatol Photo-immunol Photomed 2008;24:67-71.
48. Internet information: http//:www.DyaDerm.
49. Wennberg AM, Gudmundson F, Stenquist B, Ternesten A, Molne L, Rosen A, Larkö O. In vivo detection of basal cell carcinoma using imaging spectroscopy. Acta Dermatol Venereol 1999;79:54-61.
50. Bernard E, Bubois JL, Wepeirre J. Importance of sebaceous glands in cutaneous penetration of an antiandrogen: Target effect of liposomes. J Pharm Sci 1997;86:573-578.
51. Zaballos P, Ara M, Puig S, Malvehy J. Dermoscopy of sebaceous hyperplasia. Arch Dermatol 2005;141:808.
52. Stolz W, Braun-Falco O, Bilek P, Landthaler M, Burgdorf HC, Cognetta AB. Color atlas of dermatoscopy, Vol. 6.3, 2nd edition. Berlin: Blackwell Wissenschafts-Verlag, Blackwell Publishing Company; 2002. pp 76-81, 135.